{"contentid": 488255, "importid": NaN, "name": "More snakes added to label for antivenom product", "introduction": "Tennessee, USA-based firm Rare Disease Therapeutics (RDT) has secured a new expanded indication for its antivenom product Anavip (crotalidae immune).", "content": "<p>Tennessee, USA-based firm Rare Disease Therapeutics (RDT) has secured a new expanded indication for its antivenom product Anavip (crotalidae immune).</p>\n<p>The privately-held company has been granted a broader label for the product, to include treatment of snake bites from rattlesnakes, copperheads, and cottonmouth or water moccasins.</p>\n<p>The product was previously indicated for the management of adult and pediatric patients with North American rattlesnake envenomation.</p>\n<p>RDT exclusively markets Anavip in the USA, in partnership with manufacturer Laboratorios Silanes, a Mexico-based antivenom specialist.</p>\n<p>It is estimated that around 7,000&ndash;8,000 people are bitten by venomous snakes in the USA annually, with many suffering blood clotting disorders as a long-term consequence.</p>\n<p>One of the goals of treatment is to limit the potential incidence of such disorders. Anavip has been specifically engineered with a long half-life to minimize the likelihood of re-emergent venom effects, which commonly require additional doses.</p>\n<p>Chief executive Milton Ellis said: &ldquo;This new expanded indication demonstrates not only the remarkable scientific value of Anavip, but also the significant unmet need for treatment options that has existed for North American Pit Viper envenomated patients in the USA.&rdquo;</p>\n<p>He added: &ldquo;After decades of focus on this overlooked patient need, we are pleased to provide the thousands of North American Pit Viper envenomated patients in the USA with a new treatment option, furthering RDT&rsquo;s mission of bringing necessary treatments for rare conditions to market.&rdquo;</p>", "date": "2021-04-06 10:44:00", "meta_title": NaN, "meta_keywords": "product, antivenom, Anavip, expanded, indication, rare, label, treatment, snakes, Therapeutics, Disease, firm, added, USA-based, secured, Tennessee, immune", "meta_description": "Tennessee, USA-based firm Rare Disease Therapeutics (RDT) has secured a new expanded indication for its antivenom product Anavip (crotalidae immune).", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-06 10:26:45", "updated": "2021-04-06 10:52:00", "access": NaN, "url": "https://www.thepharmaletter.com/article/more-snakes-added-to-label-for-antivenom-product", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "fda_big.jpg", "image2id": "fda_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Rare diseases", "topic_tag": "Focus On, Regulation, Research, US FDA", "geography_tag": "USA", "company_tag": "Rare Disease Therapeutics (RDT)", "drug_tag": "Anavip", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-06 10:44:00"}